Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/7721
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTeng, Poi Leng.en_US
dc.date.accessioned2008-09-18T07:50:12Z-
dc.date.available2008-09-18T07:50:12Z-
dc.date.copyright2004en_US
dc.date.issued2004-
dc.identifier.urihttp://hdl.handle.net/10356/7721-
dc.description.abstractThe pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" value driver is able to add value and create shareholders' wealth by exploring the various roles of strategic alliances. This study hopes to provide a better understanding of strategic alliances and thus, help shape proposals for improved information disclosure on organizational capital.en_US
dc.rightsNanyang Technological Universityen_US
dc.subjectDRNTU::Business::Industries and labor-
dc.titleR&D, strategic alliances and shareholder value in biotech industry.en_US
dc.typeThesisen_US
dc.contributor.supervisorTan, Patricia Mui Siangen_US
dc.contributor.schoolCollege of Business (Nanyang Business School)en_US
dc.description.degreeMaster of Accountancyen_US
item.fulltextWith Fulltext-
item.grantfulltextrestricted-
Appears in Collections:NBS Theses
Files in This Item:
File Description SizeFormat 
NBS-THESES_629.pdf
  Restricted Access
19.58 MBAdobe PDFView/Open

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.